1. Kumral E, Tarlaci S. Vaskuler demanslar. NoroPsikiyatri Arþivi. 1999; 36: 90-96. |
|
2. Narayan SK, Gorman G, Kalaria RN, Ford GA, Chinnery PF. The minimum prevalence of cadasil in England. Neurology. 2012; in press. [DOI via Crossref] |
|
3. Boussier Mg, Tournier- Lasserve E. Summary of the proceedings of the first International Workshop on CADASIL. Stroke. 1994; 25: 704-707. |
|
4. Sabbadini G, Francia A, Calandriello L ve ark. Cerebral Autosomal Dominant Arteriopathy with subcortical infarcts and leukoencephalopathy. Brain. 1995; 118: 207-215 [DOI via Crossref] [Pubmed] |
|
5. Mas JL, Dilouya A, de Recando J. A familial disorder with subcortical ischemic strokes, dementia and leukoencephalopathy. Neurology. 1992; 42: 1015-1019. [DOI via Crossref] [Pubmed] |
|
6. Donnini I, Nannucci s, Valenti R, Pescini F, Bianchi S, Inzitari D, Pantoni L. Acetozolamide fort he migrain in Cadasil. J Headache Pain. 2012; inpress. |
|
7. Monteiro C, Barros J, Tipa R, Pereira-Monteiro J. Sporadic hemiplegic migraine as the initial manifestation of Cadasil. Cephalalgia. 2012; 32: 255-257. [DOI via Crossref] [Pubmed] |
|
8. Benisty S, Reyes S, Godin O, Herve D, Zieren N, Jouvent E, Zho Y, During M, Dichans M, Chabriat H. White matter lesions without lacuner infarcts in Cadasil. J Alzheimers Dis. 2012; in pres. |
|
9. Dominquez-Sanchez FJ, Lasa-Aristu A, Gomi-Imizcoz M. Intelligence impairment, personality and psychopathology disturbances in a familiy affected with Cadasil. Span J Psychol. 2011; 14: 936-943. [DOI via Crossref] |
|
10. Chabriat H, Vahedi K, Ãba- Zizen MT ve ark. Clinical spectrum of CADASIL: a study of seven families. Lancet 1995; 346: 934-939. [DOI via Crossref] |
|
11. Penton AL, Leonard LD, Spinner NB. Notch signaling in human development and disease. Semin Cell Dev Biol. 2012; in pres. |
|
12. Uchino M. The pathomechanism and treatment of CADASIL. Rinsho Shinkeigaku. 2011; 51: 945-948. [DOI via Crossref] [Pubmed] |
|
13. Joutel A, Corpechot C, Ducros A ve ark. Notch3 mutations in CADASIL , a hereditary adult-onset condition causing stroke and dementia. Nature 1996; 383:707-710 [DOI via Crossref] [Pubmed] |
|
14. Yuan P, Salvadore G, Li X ve ark. Valproate activates the Notch3/ cFlip signaling cascade: a strategy to attenuate white matter hyperintensities in bipolar disorder in late life? Bipolar Disord 2009; 11(3): 256-269 [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|
15. Reyes S, Kurtzs A, Herve D, Tournier-Lasserve E, Chabriat H. Presymptomatic genetic testing in CADASIL. J Neurol. 2012; in pres. |
|
16. Gunda B, Herve D, Godin O, Bruno M, Reyes S, Alili N, Opherk C, Jouvent E, During M, Bousser MG, Dichgans M, Chabriat H. Effects of gender on the phenothype of CADASIL. Stroke. 2012; 43: 137-143. [DOI via Crossref] [Pubmed] |
|
17. Kumar L, Mahr G. CADASIL Presenting as Bipolar Disorder. Psychosomatics 1997; 38: 397-398 [DOI via Crossref] |
|
18. Ãver MF. Migren baþagrili hastalarda beyaz cevher lezyonlarinin klinik ve laboratuar ozellikleri. Tez çaliþmasi. Ãukurova Ãniversitesi Tip Fakultesi. Adana 2008. |
|
19. Aylward EH, Roberts- Twillie JV, Barta PE ve ark. Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder. Am J Psychiatry. 1994; 151: 687-693 [Pubmed] |
|
20. Ãakir S, Ãçok A. Biliþsel bozukluk açisindan Ãizofreni ve Bipolar Bozukluk. Noropsikiyatri Arþivi. 2010; 47: 150-157. |
|
21. Brookes RL, Willis TA, Patel B, Morris RG, Markus HS. Depressive symptoms as apredictor of quality of life in cerebral small vessel disease. Int J Stroke. 2012; inpress. |
|